Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease (META-HEALTH)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Arshed A. Quyyumi, Emory University
ClinicalTrials.gov Identifier:
NCT00101517
First received: January 10, 2005
Last updated: September 12, 2014
Last verified: September 2014
  Purpose

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study seeks to systematically characterize potential ethnic differences in obesity-related CVD by drawing upon the fields of psychology, physiology, biochemistry, nursing, and clinical medicine.


Condition
Cardiovascular Diseases
Heart Diseases
Obesity
Metabolic Syndrome X

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership

Resource links provided by NLM:


Further study details as provided by Emory University:

Enrollment: 4024
Study Start Date: September 2004
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   30 Years to 78 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

African-American and white residents in the metro Atlanta area (Cobb, DeKalb, Fulton, Gwinnett counties) aged 30-78 years

Criteria
  • African-American or White residents of the metro Atlanta area
  • aged 30-78 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00101517

Locations
United States, Georgia
Morehouse School of Medicine
Atlanta, Georgia, United States, 30310
Emory University School
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Gary Gibbons Morehouse School of Medicine
Principal Investigator: Arshed Quyyumi Emory University
  More Information

No publications provided

Responsible Party: Arshed A. Quyyumi, Principal Investigator, Emory University
ClinicalTrials.gov Identifier: NCT00101517     History of Changes
Other Study ID Numbers: IRB00024856a, U01HL079156, U01 HL79156, U01 HL79214, 1284
Study First Received: January 10, 2005
Last Updated: September 12, 2014
Health Authority: United States: Federal Government
United States: Institutional Review Board

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on September 18, 2014